You are here

India's cough syrup ban hits Pfizer, Abbott units

Their products are among 344 fixed-dose combination drugs prohibited by regulators
Tuesday, March 15, 2016 - 05:50

Shares of Pfizer Ltd fell as much as 8 per cent after the drugmaker said it stopped selling its version of the medicine that has just been banned by Indian regulators.


PFIZER Inc and Abbott Laboratories on Monday said they would comply with a ban on a popular cough syrup in India after it was added to a local list of prohibited drugs, sending shares in the US firms' Indian subsidiaries tumbling.

Pfizer's Corex-brand syrup and Abbott's

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom